Dry eye disease (DED) is a multifactorial disease that results in symptoms of discomfort, visual disturbance, and damage to the ocular surface. Because chronic inflammation plays an important role in DED, treatment with topical corticosteroids has been demonstrated to ameliorate the signs and symptoms of the disease. Although these agents have proven short-term efficacy, their long-term use may cause intraocular pressure elevation and cataract progression. A carefully review of the different studies shows that differences between corticosteroids may exist regarding the incidence of side effects and evidence of efficacy in DED patients.

The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome

CUTOLO, CARLO ALBERTO;BARABINO, STEFANO;BONZANO, CHIARA;TRAVERSO, CARLO
2019-01-01

Abstract

Dry eye disease (DED) is a multifactorial disease that results in symptoms of discomfort, visual disturbance, and damage to the ocular surface. Because chronic inflammation plays an important role in DED, treatment with topical corticosteroids has been demonstrated to ameliorate the signs and symptoms of the disease. Although these agents have proven short-term efficacy, their long-term use may cause intraocular pressure elevation and cataract progression. A carefully review of the different studies shows that differences between corticosteroids may exist regarding the incidence of side effects and evidence of efficacy in DED patients.
File in questo prodotto:
File Dimensione Formato  
pre-print.pdf

accesso chiuso

Tipologia: Documento in Post-print
Dimensione 271.6 kB
Formato Adobe PDF
271.6 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/876460
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 30
social impact